Hannan Fleiman
Director/Board Member at ABACUS HEALTH PRODUCTS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joseph del Moral | M | 45 |
CanvasRx, Inc.
 CanvasRx, Inc. Miscellaneous Commercial ServicesCommercial Services CanvasRx, Inc. provides medical cannabis patient outreach service. The company was founded by Joseph Del Moral, Hannan Fleiman and Leo Liao in 2014 and is headquartered in Toronto, Canada.
Field Trip Health, Inc.
 Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada.
Field Trip Psychedelics, Inc.
 Field Trip Psychedelics, Inc. Medical/Nursing ServicesHealth Services Field Trip Psychedelics, Inc. operates as a mental wellness company. It offers psychedelics and psychedelic-enhanced therapies. The company was founded on April 2, 2019 and is headquartered in Toronto, Canada.
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | 5 years |
| Ronan Levy | M | 45 |
Field Trip Health, Inc.
Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada.
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.
Field Trip Psychedelics, Inc.
Field Trip Psychedelics, Inc. Medical/Nursing ServicesHealth Services Field Trip Psychedelics, Inc. operates as a mental wellness company. It offers psychedelics and psychedelic-enhanced therapies. The company was founded on April 2, 2019 and is headquartered in Toronto, Canada. | 5 years |
| Syed Mujeeb Jafferi | M | 41 |
Field Trip Health, Inc.
Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada.
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.
Field Trip Psychedelics, Inc.
Field Trip Psychedelics, Inc. Medical/Nursing ServicesHealth Services Field Trip Psychedelics, Inc. operates as a mental wellness company. It offers psychedelics and psychedelic-enhanced therapies. The company was founded on April 2, 2019 and is headquartered in Toronto, Canada. | 5 years |
| Dieter Weinand | M | 63 |
Field Trip Psychedelics, Inc.
Field Trip Psychedelics, Inc. Medical/Nursing ServicesHealth Services Field Trip Psychedelics, Inc. operates as a mental wellness company. It offers psychedelics and psychedelic-enhanced therapies. The company was founded on April 2, 2019 and is headquartered in Toronto, Canada.
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.
Field Trip Health, Inc.
Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada. | 4 years |
| Helen Boudreau | F | 58 |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.
Field Trip Psychedelics, Inc.
Field Trip Psychedelics, Inc. Medical/Nursing ServicesHealth Services Field Trip Psychedelics, Inc. operates as a mental wellness company. It offers psychedelics and psychedelic-enhanced therapies. The company was founded on April 2, 2019 and is headquartered in Toronto, Canada.
Field Trip Health, Inc.
Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada. | 4 years |
| Gregory Mayes | M | 55 |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | 2 years |
| Ryan Yermus | M | 43 |
Field Trip Health, Inc.
Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada.
Field Trip Psychedelics, Inc.
Field Trip Psychedelics, Inc. Medical/Nursing ServicesHealth Services Field Trip Psychedelics, Inc. operates as a mental wellness company. It offers psychedelics and psychedelic-enhanced therapies. The company was founded on April 2, 2019 and is headquartered in Toronto, Canada. | 5 years |
| Phillip Charles Henderson | M | 83 | 5 years | |
| Curtis Weber | M | - |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | 2 years |
| Eyal Rosenthal | M | 49 | 5 years | |
| Ellen Lubman | F | 48 |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | 3 years |
| Barry Fishman | M | 67 |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | 3 years |
| Bharat Madhavan | M | 42 | - | |
| Robert Alexander | M | - |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | 1 years |
| Matt Emmer | M | - |
Field Trip Health, Inc.
Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada. | 5 years |
| Ansbert Gadicke | M | 66 |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | - |
| Perry Antelman | M | 59 | 8 years | |
| Fred Grossman | M | 62 |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | 1 years |
| Edward Smith | M | 53 |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | 2 years |
| Daniel L. Goldberg | M | - |
Field Trip Health, Inc.
Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada. | 5 years |
| Kristen Laguerre | F | - |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | - |
| Nathan Bryson | M | 61 |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | 2 years |
| Jonathan See | M | - |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cindy Ward | F | - |
McMaster University
| 21 years |
| Ryan Mitchell | M | - |
McMaster University
| 10 years |
| Henry Hague | M | 52 | 2 years | |
| David Fidler | M | - |
McMaster University
| 2 years |
| Munir Shahin | M | - |
McMaster University
| 5 years |
| Jesse Kaplan | M | 41 | 2 years | |
| Kris Somers | M | - |
McMaster University
| 5 years |
| Michael Li | M | - |
McMaster University
| 7 years |
| Ted Ingemar Jakob Fjällman | M | 46 |
University of Guelph
| 6 years |
| Paula Hewitt | F | 52 |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | - |
| Declan Keogh | M | - |
McMaster University
| 7 years |
| Anthony Makdessi | M | - |
McMaster University
| 4 years |
| Nitin Chopra | M | - |
McMaster University
| 4 years |
| Annette Marleau | M | - |
University of Guelph
| 1 years |
| Leo Liao | M | - |
CanvasRx, Inc.
CanvasRx, Inc. Miscellaneous Commercial ServicesCommercial Services CanvasRx, Inc. provides medical cannabis patient outreach service. The company was founded by Joseph Del Moral, Hannan Fleiman and Leo Liao in 2014 and is headquartered in Toronto, Canada. | - |
| John McNair | M | - |
McMaster University
| 1 years |
| Matt O'Meara | M | - |
McMaster University
| 4 years |
| Laura Cooper | F | - |
McMaster University
| 4 years |
| Maaz Razi | M | - |
McMaster University
| 5 years |
| Simon Deeley | M | - |
McMaster University
| 4 years |
| Yong Wang | M | 51 |
McMaster University
| 2 years |
| Christopher Northey | M | - |
University of Guelph
| 4 years |
| Jonathan Dwyer | M | - |
McMaster University
| 4 years |
| Daniel William Meister | M | - |
University of Guelph
| 4 years |
| Michael Verbora | M | - |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | - |
| Quanlin Gu | M | - |
McMaster University
| 2 years |
| Aviva Asnis-Alibozek | M | - |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | 1 years |
| Atkins Dondo | M | - |
McMaster University
| 3 years |
| Yang Kong | M | 44 |
McMaster University
| 4 years |
| Yeung Alvin Hung | M | 44 |
McMaster University
| 4 years |
| Natalie Smith | F | - |
McMaster University
| 3 years |
| Ryan Wykes | M | - |
McMaster University
| 4 years |
| Karim Harji | M | - |
McMaster University
| 4 years |
| Tom Glawdel | M | 40 |
McMaster University
| 4 years |
| Sen Sen Liu | M | 42 |
McMaster University
| 4 years |
| Amardeep Manhas | M | 41 |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | - |
| Maher Jamal | M | - |
McMaster University
| 4 years |
| Katharine Tomko | F | - |
University of Guelph
| 4 years |
| Saad Umerani | M | - |
McMaster University
| 4 years |
| Jason Atkinson | M | 36 |
McMaster University
| 5 years |
| Omair Muzzaffer Ansari | M | - |
McMaster University
| 4 years |
| Alexandra Mulkewytch | F | - |
McMaster University
| 4 years |
| Matt Peden | M | - |
University of Guelph
| 4 years |
| Vladimir Vasilenko | M | 59 |
University of Guelph
| 4 years |
| Mike Ye | M | - |
McMaster University
| 4 years |
| Jessica Kennedy | F | - |
University of Guelph
| 4 years |
| Victor Cheung | M | - |
McMaster University
| 4 years |
| Ryan Hanley | M | - |
McMaster University
| 4 years |
| James Doran | M | - |
University of Guelph
| 3 years |
| Jun Feng Wang | M | 50 |
McMaster University
| 2 years |
| Frederick Biro | M | - |
McMaster University
| 4 years |
| Kent Peters | M | 51 |
University of Guelph
| 2 years |
| Matthew Griffiths | M | - |
McMaster University
| 2 years |
| Matthew Gibson | M | - |
McMaster University
| 2 years |
| Amy Olah | F | - |
University of Guelph
| 4 years |
| Jamie Murray | M | - |
University of Guelph
| 2 years |
| Lisa Crossley | M | - |
McMaster University
| 1 years |
| David Hogarth | M | - |
McMaster University
| 4 years |
| Song Wu | M | - |
McMaster University
| 2 years |
| Brandt Blimkie | M | - |
McMaster University
| 1 years |
| Matteo Tino | M | - |
McMaster University
| 4 years |
| Darren Timmer | M | - |
University of Guelph
| 1 years |
| Ryan T. Goulding | M | - |
McMaster University
| 2 years |
| Richard Gervais | M | - |
McMaster University
| 4 years |
| Patrick Thompson | M | - |
University of Guelph
| 4 years |
| Thy Dinh | M | - |
McMaster University
| 4 years |
| Yan Zhao | M | 44 |
McMaster University
| 2 years |
| Sonya Gulati | F | - |
McMaster University
| 1 years |
| Kat Perunova | F | - |
University of Guelph
| 4 years |
| Fadi Habib | M | - |
McMaster University
| 2 years |
| Jack Gauldie | M | - |
McMaster University
| 16 years |
| Patrick J. O'Rourke | M | - |
McMaster University
| 4 years |
| Savironi Chet | F | - |
McMaster University
| 5 years |
| Derek Macpherson | M | - |
McMaster University
| 4 years |
| John MaGee | M | - |
McMaster University
| 4 years |
| Jeremy L. Bau | M | - |
McMaster University
| 4 years |
| Rochelle Henry | F | - |
McMaster University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hannan Fleiman
- Personal Network
